Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk.

Which has preferable earnings & valuation, TLX or TEVA?

Telix Pharmaceuticals Limited American Depositary Shares has higher earnings, but lower revenue than Teva Pharmaceutical Industries.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telix Pharmaceuticals Limited American Depositary Shares	$783.21M	7.55	N/A	N/A	N/A
Teva Pharmaceutical Industries	$16.62B	1.21	-$1.64B	-$1.15	-15.29

Does the MarketBeat Community believe in TLX or TEVA?

Teva Pharmaceutical Industries received 1336 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.95% of users gave Teva Pharmaceutical Industries an outperform vote.

Company	Underperform	Outperform
Telix Pharmaceuticals Limited American Depositary Shares	Outperform Votes 6 100.00%	Underperform Votes No Votes
Teva Pharmaceutical Industries	Outperform Votes 1342 67.95%	Underperform Votes 633 32.05%

Is TLX or TEVA more profitable?

Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Telix Pharmaceuticals Limited American Depositary Shares	N/A	N/A	N/A
Teva Pharmaceutical Industries	-9.91%	42.46%	6.65%

Do institutionals & insiders believe in TLX or TEVA?

54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media refer more to TLX or TEVA?

In the previous week, Teva Pharmaceutical Industries had 5 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 18 mentions for Teva Pharmaceutical Industries and 13 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Telix Pharmaceuticals Limited American Depositary Shares' average media sentiment score of 0.86 beat Teva Pharmaceutical Industries' score of 0.43 indicating that Telix Pharmaceuticals Limited American Depositary Shares is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Telix Pharmaceuticals Limited American Depositary Shares	3 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Teva Pharmaceutical Industries	7 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer TLX or TEVA?

Telix Pharmaceuticals Limited American Depositary Shares presently has a consensus target price of $22.00, suggesting a potential upside of 25.71%. Teva Pharmaceutical Industries has a consensus target price of $24.44, suggesting a potential upside of 39.05%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher possible upside, analysts plainly believe Teva Pharmaceutical Industries is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Telix Pharmaceuticals Limited American Depositary Shares	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Teva Pharmaceutical Industries	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	3.20

Summary

Teva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 11 of the 15 factors compared between the two stocks.